Revenio Group Corporation: Further questions related to FDA permit application are now answered
Revenio Group Corporation, Stock Exchange Release, 15 February 2016 at 8:00 FURTHER QUESTIONS RELATED TO FDA PERMIT APPLICATION ARE NOW ANSWERED Icare Finland Oy, a subsidiary of Revenio Group, submitted in September a sales permit application - for its HOME tonometer for monitoring eye pressure at home - to the United States Food and Drug Administration (FDA). In November, Icare received from the FDA a list of further questions, which have now been answered. Revenio cannot estimate accurately when the FDA decision will be obtained. The Corporation is prepared that the permit would